UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 530

Sortiert nach

A New Method for Computing Reliable Sample Size for Prescribing Soil Test Based Nutrient Management Interventions

Communications in Soil Science and Plant Analysis, 2019-11, Vol.50 (21), p.2701-2717

2019

Volltextzugriff (PDF)

Randomised clinical trial: a phase 1, dose‐ranging study of the anti‐matrix metalloproteinase‐9 monoclonal antibody GS‐5745 versus placebo for ulcerative colitis

Alimentary pharmacology & therapeutics, 2016-07, Vol.44 (2), p.157-169

2016

Volltextzugriff (PDF)

Sofosbuvir plus ribavirin in treatment‐naïve patients with chronic hepatitis C virus genotype 1 or 3 infection in India

Journal of viral hepatitis, 2017-05, Vol.24 (5), p.371-379

2017

Volltextzugriff (PDF)

High Rates of Svr12 in Adolescents Treated with the Combination of Ledipasvir/Sofosbuvir

Journal of hepatology, 2016, Vol.64 (2), p.S184-S185

2016

Volltextzugriff (PDF)

Swaraj and the Reluctant State

1, 2020

Volltextzugriff (PDF)

Acute exacerbation of COPD : Factors associated with poor treatment outcome

Chest, 2000-03, Vol.117 (3), p.662-671

2000

Volltextzugriff (PDF)

Cytomegalovirus Infection in Postrenal Transplant Recipients: 18 Years’ Experience From a Tertiary Referral Center

Transplantation proceedings, 2020-12, Vol.52 (10), p.3173-3178

2020

Volltextzugriff (PDF)

O8 SUCCESSFUL RETREATMENT WITH SOFOSBUVIR-CONTAINING REGIMENS FOR HCV GENOTYPE 2 OR 3 INFECTED PATIENTS WHO FAILED PRIOR SOFOSBUVIR PLUS RIBAVIRIN THERAPY

Journal of hepatology, 2014-04, Vol.60 (1), p.S4-S5

2014

Volltextzugriff (PDF)

68 ANTIVIRAL EFFICACY OF THE NS3 PROTEASE INHIBITOR, GS-9451, NON-NUCLEOSIDE NS5b INHIBITOR, TEGOBUVIR, AND PEGYLATED INTERFERON PLUS RIBAVIRIN IN TREATMENT-NAÏVE GENOTYPE 1 HEPATITIS C INFECTED PATIENTS

Journal of hepatology, 2013-04, Vol.58, p.S31-S31

2013

Volltextzugriff (PDF)

Safety and efficacy of autologous mesenchymal stromal cells transplantation in patients undergoing living donor kidney transplantation: A pilot study

Nephrology (Carlton, Vic.), 2015-01, Vol.20 (1), p.25-33

2015

Volltextzugriff (PDF)

O55 SUCCESSFUL RETREATMENT WITH SOFOSBUVIR OF HCV GENOTYPE-1 INFECTED PATIENTS WHO FAILED PRIOR THERAPY WITH PEGINTERFERON + RIBAVIRIN PLUS 1 OR 2 ADDITIONAL DIRECT-ACTING ANTIVIRAL AGENTS

Journal of hepatology, 2014-04, Vol.60 (1), p.S23-S23

2014

Volltextzugriff (PDF)

865 12 WEEK RESPONSE-GUIDED TREATMENT WITH THE NS5A INHIBITOR, GS-5885, THE NS3 PROTEASE INHIBITOR, GS-9451, PLUS PEGYLATED INTERFERON/RIBAVIRIN IN TREATMENT NAÏVE GENOTYPE 1 HEPATITIS C INFECTED PATIENTS

Journal of hepatology, 2013-04, Vol.58, p.S355-S355

2013

Volltextzugriff (PDF)

13 COMBINATION OF THE NS5A INHIBITOR, GS-5885, THE NS3 PROTEASE INHIBITOR, GS-9451, AND PEGYLATED INTERFERON PLUS RIBAVIRIN IN TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 HEPATITIS C INFECTION

Journal of hepatology, 2013-04, Vol.58, p.S6-S6

2013

Volltextzugriff (PDF)

OP39 Treatment of ulcerative colitis With AMT-101, a novel oral interleukin-10 immunomodulatory fusion biologic that traffics across the intestinal epithelium

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S039-S040

2020

Volltextzugriff (PDF)

813 - Process Development and Manufacturing: A NEEDLE-BASED AUTOSAMPLER FOR BIOREACTOR CELL MEDIA COLLECTION

Cytotherapy (Oxford, England), 2023-05, Vol.25 (6), p.S172-S172

2023

Volltextzugriff (PDF)

Process Development and Manufacturing: A NEEDLE-BASED AUTOSAMPLER FOR BIOREACTOR CELL MEDIA COLLECTION

Cytotherapy (Oxford, England), 2023-05, Vol.25 (6), p.S172

2023

Volltextzugriff (PDF)

891 - Process Development and Manufacturing: DIGITAL TWIN-ENABLED FEEDBACK-CONTROLLED AUTOMATION WITH INTEGRATED PROCESS ANALYTICS FOR BIOMANUFACTURING OF CELL THERAPIES

Cytotherapy (Oxford, England), 2023-05, Vol.25 (6), p.S206-S207

2023

Volltextzugriff (PDF)

Process Development and Manufacturing: DIGITAL TWIN-ENABLED FEEDBACK-CONTROLLED AUTOMATION WITH INTEGRATED PROCESS ANALYTICS FOR BIOMANUFACTURING OF CELL THERAPIES

Cytotherapy (Oxford, England), 2023-05, Vol.25 (6), p.S206-S207

2023

Volltextzugriff (PDF)

Effect of Gibberellic acid and benzyl adenine on ornamental plants: A review

The pharma innovation, 2023-01, Vol.12 (2), p.101-105

2023

Volltextzugriff (PDF)

P584 Efficacy, safety, and tolerability of AMT-101, a gut selective oral IL-10 fusion, in the Phase 2 FILLMORE trial of patients with chronic pouchitis

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i712-i713

2023

Volltextzugriff (PDF)

P294 AMT-101, a gut selective oral IL-10 fusion: results from a Phase 1b study in patients with active Ulcerative Colitis

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S324-S325

2021

Volltextzugriff (PDF)

Utility of quantitative real time PCR in detection and monitoring of viral infections in post renal transplant recipients

Indian journal of transplantation, 2016-01, Vol.10 (1), p.9-14

2016

Volltextzugriff (PDF)

Persistent systemic inflammation and atypical enterocolitis in patients with NEMO syndrome

Clinical immunology (Orlando, Fla.), 2009-07, Vol.132 (1), p.124-131

2009

Volltextzugriff (PDF)

P047 Therapeutic dosing of filgotinib (GS-6034, GLPG0634) is efficacious in the mouse DSS model of colitis

Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S101-S102

2017

Volltextzugriff (PDF)

GS17 - High Rates of Svr12 in Adolescents Treated with the Combination of Ledipasvir/Sofosbuvir

Journal of hepatology, 2016, Vol.64 (2), p.S184-S185

2016

Volltextzugriff (PDF)

1 – 25 von 530

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(452)
Mit Volltextzugriff
(478)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(281)
Life Sciences & Biomedicine
(224)
Humans
(144)
Biological And Medical Sciences
(95)
Female
(74)
Male
(74)
Animals
(68)
Medical Sciences
(67)
Gastroenterology And Hepatology
(52)
Physical Sciences
(49)
Middle Aged
(45)
Adult
(36)
Mice
(35)
Fundamental And Applied Biological Sciences. Psychology
(32)
Gastroenterology & Hepatology
(28)
Aged
(26)
Dermatology
(26)
Agriculture
(24)
Technology
(23)
Gastroenterology. Liver. Pancreas. Abdomen
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

A New Method for Computing Reliable Sample Size for Prescribing Soil Test Based Nutrient Management Interventions

Randomised clinical trial: a phase 1, dose‐ranging study of the anti‐matrix metalloproteinase‐9 monoclonal antibody GS‐5745 versus placebo for ulcerative colitis

Sofosbuvir plus ribavirin in treatment‐naïve patients with chronic hepatitis C virus genotype 1 or 3 infection in India

High Rates of Svr12 in Adolescents Treated with the Combination of Ledipasvir/Sofosbuvir

Swaraj and the Reluctant State

Acute exacerbation of COPD : Factors associated with poor treatment outcome

Cytomegalovirus Infection in Postrenal Transplant Recipients: 18 Years’ Experience From a Tertiary Referral Center

O8 SUCCESSFUL RETREATMENT WITH SOFOSBUVIR-CONTAINING REGIMENS FOR HCV GENOTYPE 2 OR 3 INFECTED PATIENTS WHO FAILED PRIOR SOFOSBUVIR PLUS RIBAVIRIN THERAPY

68 ANTIVIRAL EFFICACY OF THE NS3 PROTEASE INHIBITOR, GS-9451, NON-NUCLEOSIDE NS5b INHIBITOR, TEGOBUVIR, AND PEGYLATED INTERFERON PLUS RIBAVIRIN IN TREATMENT-NAÏVE GENOTYPE 1 HEPATITIS C INFECTED PATIENTS

Safety and efficacy of autologous mesenchymal stromal cells transplantation in patients undergoing living donor kidney transplantation: A pilot study

O55 SUCCESSFUL RETREATMENT WITH SOFOSBUVIR OF HCV GENOTYPE-1 INFECTED PATIENTS WHO FAILED PRIOR THERAPY WITH PEGINTERFERON + RIBAVIRIN PLUS 1 OR 2 ADDITIONAL DIRECT-ACTING ANTIVIRAL AGENTS

865 12 WEEK RESPONSE-GUIDED TREATMENT WITH THE NS5A INHIBITOR, GS-5885, THE NS3 PROTEASE INHIBITOR, GS-9451, PLUS PEGYLATED INTERFERON/RIBAVIRIN IN TREATMENT NAÏVE GENOTYPE 1 HEPATITIS C INFECTED PATIENTS

13 COMBINATION OF THE NS5A INHIBITOR, GS-5885, THE NS3 PROTEASE INHIBITOR, GS-9451, AND PEGYLATED INTERFERON PLUS RIBAVIRIN IN TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 HEPATITIS C INFECTION

OP39 Treatment of ulcerative colitis With AMT-101, a novel oral interleukin-10 immunomodulatory fusion biologic that traffics across the intestinal epithelium

813 - Process Development and Manufacturing: A NEEDLE-BASED AUTOSAMPLER FOR BIOREACTOR CELL MEDIA COLLECTION

Process Development and Manufacturing: A NEEDLE-BASED AUTOSAMPLER FOR BIOREACTOR CELL MEDIA COLLECTION

891 - Process Development and Manufacturing: DIGITAL TWIN-ENABLED FEEDBACK-CONTROLLED AUTOMATION WITH INTEGRATED PROCESS ANALYTICS FOR BIOMANUFACTURING OF CELL THERAPIES

Process Development and Manufacturing: DIGITAL TWIN-ENABLED FEEDBACK-CONTROLLED AUTOMATION WITH INTEGRATED PROCESS ANALYTICS FOR BIOMANUFACTURING OF CELL THERAPIES

Effect of Gibberellic acid and benzyl adenine on ornamental plants: A review

P584 Efficacy, safety, and tolerability of AMT-101, a gut selective oral IL-10 fusion, in the Phase 2 FILLMORE trial of patients with chronic pouchitis

P294 AMT-101, a gut selective oral IL-10 fusion: results from a Phase 1b study in patients with active Ulcerative Colitis

Utility of quantitative real time PCR in detection and monitoring of viral infections in post renal transplant recipients

Persistent systemic inflammation and atypical enterocolitis in patients with NEMO syndrome

P047 Therapeutic dosing of filgotinib (GS-6034, GLPG0634) is efficacious in the mouse DSS model of colitis

GS17 - High Rates of Svr12 in Adolescents Treated with the Combination of Ledipasvir/Sofosbuvir

Suchergebnisse filtern